Professor Alberto Bernabe -
The John Marshall Law School
Monday, October 11, 2010
On the implications of the FDA's request to withdraw Meridia
The decision late last week by the FDA to encourage Abbott Laboratories to withdraw its Meridia diet pill has obvious implications for other drugmakers seeking approval for obesity drugs. Pharmalot has a comment on the subject here.